丹诺医药-B（股票代码：06872）于2026年8月3日发布2026年7月股份变动月报表，报告期为2026年7月1日至7月31日。根据公告，截至报告期末，公司普通股H股已发行股份数为52,328,926股，与上个月末保持一致。
公告显示，报告期内公司已发行及注册股本无新增或减少情况，普通股H股的已发行股份由上月底的52,328,926股保持不变，库藏股数量亦为0股。公司未发生任何股份购回、注销及新发行情况，也未披露股份期权或股权激励计划相关变动事宜。公司方面确认，截至2026年7月31日，已满足联交所对公众持股量的规定。
公司现有股本总数稳定，法定/注册股本维持在人民币52,328,926元。公告同时强调，公司已依照香港联交所《上市规则》及相关法律法规履行信息披露等合规义务。该公告由公司董事会主席、执行董事、首席执行官兼总经理马振坤签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.